Prevalence and Antimicrobial Resistance Patterns of Pseudomonas aeruginosa in Urinary Tract Infections Among Children Aged 10–15 Years
Keywords:
Pseudomonas aeruginosa, Urinary tract infection, Antimicrobial resistance, Multidrug resistance, ChildrenAbstract
Background: Pseudomonas aeruginosa is an important pediatric uropathogen increasingly associated with antimicrobial resistance, complicating treatment and emphasizing the need for surveillance. Aims of the study: This study aimed to determine the prevalence of Pseudomonas aeruginosa in urinary tract infections among children aged 10–15 years and evaluate its antimicrobial susceptibility and multidrug-resistance patterns. Additionally, the study assessed the associations of P. aeruginosa infection and multidrug resistance with selected demographic and clinical factors, including previous UTI, antibiotic exposure, hospitalization, and recurrent infection. Methodology: A prospective cross-sectional study included 240 children aged 10–15 years with suspected UTI. Clean-catch midstream urine samples were cultured on blood and MacConkey agar. Pseudomonas aeruginosa was identified by colony morphology, Gram staining, oxidase testing, and standard biochemical methods. Antimicrobial susceptibility was assessed using the Kirby–Bauer disk diffusion method on Mueller–Hinton agar according to CLSI criteria, with P. aeruginosa ATCC 27853 for quality control. MDR was defined as non-susceptibility to at least one agent in three or more antimicrobial categories. Result: A prospective cross-sectional study included 240 children aged 10–15 years with suspected urinary tract infection. Clean-catch midstream urine samples were cultured on blood and MacConkey agar. Pseudomonas aeruginosa was identified using colony morphology, Gram staining, oxidase testing, and standard biochemical methods. Antimicrobial susceptibility was determined by Kirby–Bauer disk diffusion on Mueller–Hinton agar according to CLSI criteria. P. aeruginosa ATCC 27853 was used for quality control. Multidrug resistance was defined as non-susceptibility to one agent in three or more antimicrobial categories. Conclusions: Pseudomonas aeruginosa represented a clinically important cause of pediatric UTI, with considerable multidrug resistance. Previous UTI, antibiotic exposure, hospitalization, and recurrent infection were associated with MDR isolates. Carbapenems and amikacin retained the greatest activity, supporting culture-guided therapy and local resistance surveillance.